Salsalate in Patients Mild to Moderate Alzheimer's Disease

NCT03277573 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Salsalate
DRUG: Placebo

Sponsor

Adam Boxer